This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

Supernus Pharmaceuticals Inc (SUPN)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 32.98M 40.30M 48.54M 23.74M
Receivables 5.54M 675.00K 128.00K 4.87M
Inventories 7.15M 1.15M 0.00 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 97.16M 91.74M 49.40M 39.81M
Property, Plant & Equipment, Gross 8.14M 6.50M 5.75M 5.19M
Accumulated Depreciation & Depletion 5.59M 5.08M 4.44M 3.94M
Property, Plant & Equipment, Net 2.55M 1.42M 1.31M 1.25M
Intangibles 1.16M 683.00K 912.00K 1.14M
Other Non-Current Assets 10.12M 144.00K 2.11M 4.80M
Total Non-Current Assets 13.83M 2.25M 4.33M 7.20M
Liabilities & Shareholder Equity
Total Assets 111.00M 93.99M 53.73M 47.01M
Accounts Payable 3.14M 10.67M 10.08M 11.26M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 0.00 0.00 0.00 0.00
Total Current Liabilities 26.40M 22.98M 18.77M 15.21M
Long Term Debt 34.39M 11.09M 22.71M 75.00M
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 16.74M 2.35M 2.81M 1.12M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 51.13M 13.44M 25.52M 76.12M
Total Liabilities 77.53M 36.42M 44.29M 91.33M
Preferred Stock Equity 0.00 0.00 0.00 49.00K
Common Stock Equity 33.46M 57.57M 9.44M -44.37M
Common Par 40.00K 31.00K 14.00K 6.00K
Additional Paid In Capital 211.95M 143.85M 49.40M 49.41M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -178.53M -86.26M -39.97M -93.79M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 0.00 -57.00K 1.00K 0.00
Total Capitalization 67.86M 68.66M 32.15M 30.68M
Total Equity 33.46M 57.57M 9.44M -44.32M
Total Liabilities & Stock Equity 111.00M 93.99M 53.73M 47.01M
Total Common Shares Outstanding 39.98M 30.62M 23.91M 23.91M
Preferred Shares 0.00 0.00 0.00 49.00M
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 31.85M 17.44M 13.86M 0.00
Diluted Weighted Shares Outstanding 31.85M 17.44M 13.86M 0.00
Number of Employees 235 193 71 NA
Number of Part-Time Employees 0 0 0 NA
SUPN News

SUPN Supernus Pharmaceuticals Inc

Analysts Ratings for SUPN

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 3 3 3 3
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET SUPN ANALYST REPORT

Brokerage Partners

SUPN Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs